May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Effect of Basic Fibroblast Growth Factor (FGF2) on Force Generation in Rabbit Extraocular Muscle
Author Affiliations & Notes
  • L.K. McLoon
    Department of Ophthalmology, University of Minnesota, Minneapolis, MN
  • B. Anderson
    Department of Ophthalmology, University of Minnesota, Minneapolis, MN
  • S.P. Christiansen
    Department of Ophthalmology, University of Minnesota, Minneapolis, MN
  • Footnotes
    Commercial Relationships  L.K. McLoon, None; B. Anderson, None; S.P. Christiansen, None.
  • Footnotes
    Support  NIH Grant EY015313, Lew Wasserman Midcareer Merit Award from RPB (LKM), RPB, Minnesota Lions and Lionesses
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 2930. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      L.K. McLoon, B. Anderson, S.P. Christiansen; Effect of Basic Fibroblast Growth Factor (FGF2) on Force Generation in Rabbit Extraocular Muscle . Invest. Ophthalmol. Vis. Sci. 2006;47(13):2930.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : While there are drug treatments to weaken overacting muscles in strabismic patients, there are currently no drug treatments in use clinically to strengthen underacting muscles. Our previous work demonstrated that injections of either IGFI or IGFII into extraocular muscles result in increased muscle force generation. Basic fibroblast growth factor (bFGF) is a known myogenic growth factor. We tested the hypothesis that treatment of extraocular muscles with bFGF would result in increased muscle force generation.

Methods: : One superior rectus muscle of normal adult rabbits was injected with either 1 µg or 5 µg of bFGF (FGF2) in a volume of 100 µl saline. The contralateral muscle was injected with an equal volume of saline. After one and two weeks, the animals were euthanized. Both superior rectus muscles were removed and assayed physiologically using an in vitro apparatus. Muscles were stimulated at 1, 10, 20, 40, 100, 150 and 200 Hz and then subjected to a fatigue protocol.

Results: : A single injection of bFGF into the superior rectus muscles resulted in increased force generation at every stimulation frequency tested when compared to controls at one week after treatment. The 1 µg dose resulted in a 25–40% increase in force generation compared to saline–injected control muscles. At the 5 µg dose, increases in force generation of between 15 and 40% over control values were seen. By two weeks after a single injection, there was no difference in muscle force generation between treated and untreated muscles.

Conclusions: : Basic fibroblast growth factor results in a significant but short–term increase in extraocular muscle force generation. We are currently testing sustained–release delivery of bFGF to ascertain if such increases can be maintained for longer periods of time. If so, growth factors such as bFGF and IGF could prove to be very useful clinically, either alone or in combination with a weakening agent in the antagonist to treat patients with strabismus.

Keywords: strabismus: treatment • extraocular muscles: structure • growth factors/growth factor receptors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×